Internal Medicine, Pulmonary Disease · San Juan, PR
NPI
1639152499
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
735 Ave Ponce de Leon Ste 513
San Juan, PR, 00917
Phone (787) 758-7761
Medicare paid, 2024
$17K
329 services
Medicare patients, 2024
91
Average age 77
Drug cost, 2024
$1.8M
6,897 prescriptions
Company payments, 2025
$1,189
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pedro J Monroig Quiles was code 99213 (office e&m - established), 176 times for 83 patients. In total Pedro J Monroig Quiles billed 329 services in 10 codes, and Medicare paid $17K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 176 | 83 | $64.01 | $11K |
| 94375 Pulmonary Function Testing | Office | 101 | 59 | $26.92 | $2,719 |
| 99204 Office E&M - New | Office | 16 | 16 | $122.13 | $1,954 |
| 94729 Pulmonary Function Testing | Office | 11 | 11 | $44.43 | $489 |
By year: 2022 $27K for 496 services; 2023 $25K for 458 services; 2024 $17K for 329 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pedro J Monroig Quiles prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,662 prescriptions and refills. In total Pedro J Monroig Quiles wrote 6,897 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,662 | 1,693 | 554 | $69K |
| Fluticasone Propionate Generic | 865 | 1,038 | 280 | $17K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 603 | 631 | 202 | $86K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 544 | 569 | 130 | $373K |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 342 | 345 | 114 | $21K |
| Arnuity Ellipta Fluticasone Furoate | 250 | 250 | 84 | $53K |
| Montelukast Sodium Generic | 225 | 671 | 111 | $5,113 |
| Qvar Redihaler Beclomethasone Dipropionate | 217 | 229 | 88 | $58K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 213 | 233 | 64 | $49K |
| Methylprednisolone Generic | 188 | 188 | 136 | $3,543 |
| Spiriva Respimat Tiotropium Bromide | 175 | 178 | 53 | $94K |
| Atrovent Hfa Ipratropium Bromide | 124 | 129 | 44 | $59K |
| Fluticasone Propionate Hfa Fluticasone Propionate | 103 | 117 | 40 | $28K |
| Famotidine Generic | 97 | 162 | 40 | $983 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 94 | 101 | 49 | $12K |
Brand drugs: 3,481 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pedro J Monroig Quiles $1,189 ($1,189 in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $283.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 8 | $283 |
| GlaxoSmithKline, LLC. GSK | 10 | $247 |
| United Therapeutics Corporation UTHR | 9 | $192 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $126 |
| Merck Sharp & Dohme LLC MRK | 5 | $110 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $62.97 |
| Pbg Puerto Rico LLC | 2 | $48.51 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $25 |
| Amgen Inc. AMGN | 1 | $20 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.